These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28579679)

  • 1. Yttrium-90 Radioembolization for Metastatic Colorectal Cancer: Outcomes by Number of Lines of Therapy.
    Marsala A; Lee EW; Padia SA
    Semin Intervent Radiol; 2017 Jun; 34(2):116-120. PubMed ID: 28579679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioembolization in the Setting of Systemic Therapies.
    Mabud TS; Hickey R
    Semin Intervent Radiol; 2021 Oct; 38(4):472-478. PubMed ID: 34629716
    [No Abstract]   [Full Text] [Related]  

  • 3. SIR-Spheres yttrium-90 radioembolization for the treatment of unresectable liver cancers.
    Golfieri R
    Hepat Oncol; 2014 Jun; 1(3):265-283. PubMed ID: 30190962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-Based Integration of Yttrium-90 Radioembolization in the Contemporary Management of Hepatic Metastases from Colorectal Cancer.
    Wang DS; Louie JD; Sze DY
    Tech Vasc Interv Radiol; 2019 Jun; 22(2):74-80. PubMed ID: 31079714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioembolization as a Treatment Strategy for Metastatic Colorectal Cancer to the Liver: What Can We Learn from the SIRFLOX Trial?
    Sangha BS; Nimeiri H; Hickey R; Salem R; Lewandowski RJ
    Curr Treat Options Oncol; 2016 Jun; 17(6):26. PubMed ID: 27098532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated survival outcomes and analysis of long-term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal cancer liver metastases.
    Kennedy A; Cohn M; Coldwell DM; Drooz A; Ehrenwald E; Kaiser A; Nutting CW; Rose SC; Wang EA; Savin MA
    J Gastrointest Oncol; 2017 Aug; 8(4):614-624. PubMed ID: 28890810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
    Wang EA; Stein JP; Bellavia RJ; Broadwell SR
    Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yttrium-90 radioembolization as a palliative treatment for liver tumors: a case study.
    Maas L
    Clin J Oncol Nurs; 2015 Oct; 19(5):620-2. PubMed ID: 26414581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheres.
    Kennedy AS; Ball D; Cohen SJ; Cohn M; Coldwell DM; Drooz A; Ehrenwald E; Kanani S; Rose SC; Nutting CW; Moeslein FM; Savin MA; Schirm S; Putnam SG; Sharma NK; Wang EA
    J Gastrointest Oncol; 2015 Apr; 6(2):134-42. PubMed ID: 25830033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry.
    Tong AK; Kao YH; Too CW; Chin KF; Ng DC; Chow PK
    Br J Radiol; 2016 Jun; 89(1062):20150943. PubMed ID: 26943239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Combined Yttrium 90 Resin Radioembolization with Aflibercept and FOLFIRI in a Patient with Metastatic Colorectal Cancer.
    De Souza A; Daly KP; Yoo J; Saif MW
    Case Rep Oncol Med; 2015; 2015():461823. PubMed ID: 25866690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
    Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
    J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors.
    Kuei A; Saab S; Cho SK; Kee ST; Lee EW
    World J Gastroenterol; 2015 Jul; 21(27):8271-83. PubMed ID: 26217079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yttrium-90 Radioembolization of Hepatocellular Carcinoma-Performance, Technical Advances, and Future Concepts.
    Molvar C; Lewandowski R
    Semin Intervent Radiol; 2015 Dec; 32(4):388-97. PubMed ID: 26622103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision Making in Interventional Oncology: Intra-arterial Therapies for Metastatic Colorectal Cancer-Y90 and Chemoembolization.
    Fairchild AH; White SB
    Semin Intervent Radiol; 2017 Jun; 34(2):87-91. PubMed ID: 28579675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tc-99m-MAA lung shunt fraction before Y-90 radioembolization is low among patients with non-hepatocellular carcinoma malignancies.
    Elsayed M; Martin JG; Dabrowiecki A; Goldman DT; Faraj R; McMahon JT; Kokabi N; Duszak R; Newsome J; Bercu ZL
    Nucl Med Commun; 2019 Nov; 40(11):1154-1157. PubMed ID: 31568192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early treatment response evaluation after yttrium-90 radioembolization of liver malignancy with CT perfusion.
    Reiner CS; Morsbach F; Sah BR; Puippe G; Schaefer N; Pfammatter T; Alkadhi H
    J Vasc Interv Radiol; 2014 May; 25(5):747-59. PubMed ID: 24630751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond hepatocellular carcinoma and colorectal metastasis: the expanding applications of radioembolization.
    Zurkiya O; Ganguli S
    Front Oncol; 2014; 4():150. PubMed ID: 24982850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging Considerations before and after Liver-Directed Locoregional Treatments for Metastatic Colorectal Cancer.
    Chlorogiannis DD; Moussa AM; Zhao K; Alexander ES; Sofocleous CT; Sotirchos VS
    Diagnostics (Basel); 2024 Apr; 14(7):. PubMed ID: 38611685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma.
    Saini A; Wallace A; Alzubaidi S; Knuttinen MG; Naidu S; Sheth R; Albadawi H; Oklu R
    J Clin Med; 2019 Jan; 8(1):. PubMed ID: 30621040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.